MedPath

The Effects of Dance for Breast Cancer Patients Undergoing Surgical Treatment

Not Applicable
Recruiting
Conditions
Breast Cancer
Interventions
Other: Dance
Registration Number
NCT06215027
Lead Sponsor
AC Camargo Cancer Center
Brief Summary

The goal of this non randomized clinical trial, with pre- and post-intervention evaluation, longitudinal, with prospective data collection is to evaluate the effects of dance as a therapeutic intervention in breast cancer patients undergoing surgical treatment.

Detailed Description

The hypothesis is that dance will promote improvements in range of motion, strength, fatigue, functionality, pain and quality of life for breast cancer patients undergoing surgical treatment. Objectives: To evaluate the effects of dance as a therapeutic intervention in breast cancer patients undergoing surgical treatment on: shoulder range of, overall muscle strength, fatigue, respiratory muscle strength, functionality, pain and quality of life. Method: This is a non-randomized randomized clinical trial, with pre- and post-intervention evaluation, prospective data collection. The following will be used for pre-intervention assessment: goniometry, dynamometry, manovacuometry, 6-minute walk test, fatigue and quality of life questionnaire, and quality of life questionnaire, as well as a pain assessment scale. After 16 weeks, the same variables will be assessed.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • patients diagnosed with breast cancer
  • undergone surgical resection
  • after medical referral for physiotherapy
  • and physiotherapeutic assessment
Exclusion Criteria
  • patients with another previous oncological diagnosis
  • previous neuromuscular diseases
  • patients who do not agree to take part in the study
  • or the impossibility of carrying out the muscle strength assessment and/or other assessments

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
DanceDanceDance
Primary Outcome Measures
NameTimeMethod
ROMPre-intervention and after 16 weeks

Shoulder range of motion

Secondary Outcome Measures
NameTimeMethod
Overall muscle strengthPre-intervention and after 16 weeks

Dynamometer

respiratory muscle strengthPre-intervention and after 16 weeks

Maximum inspiratory and expiratory pressures (MIP and MEP)

FunctionalityPre-intervention and after 16 weeks

6 minute walk test (6MWT)

Pain intensityPre-intervention and after 16 weeks

Analogic visual scale. The visual analogue pain scale is a measure of pain intensity that has been widely used in several languages. For pain intensity, the scale is most commonly ranging from "no pain" (score of 0) to "worst pain imaginable" (score of 10). A higher rating indicates greater pain intensity.

FatiguePre-intervention and after 16 weeks

Brief Fatigue Inventory. The BFI is a scale with 11 points (0 to 10), including a dichotomous question about whether the patient felt tired or fatigued in the last 7 days. For each question, zero is considered ''no fatigue'' and 10 is ''worst fatigue possible,'' except for the dichotomous question that is not scored. Among the other questions, 3 measures the severity of fatigue in the current, daily situations, and in the last 24 hours. Six questions measure the influence of fatigue in general activities, mood, walk, work, relationship with other people, and recreation. The total score is the average of all questions. According to the total score, fatigue is classified as mild (1 to 3 points), moderate (4 to 6 points), and severe (7 to 10 points).

Quality of life (physical well-being, social and family well-being, emotional well-being, functional well-being)Pre-intervention and after 16 weeks

Functional Assessment of Cancer Therapy-Breast (FACT-B). The FACT-B, version 4, is a multidimensional questionnaire composed of 37 questions divided into five domains that assess different dimensions: physical well-being, social and family well-being, emotional well-being, functional well-being and breast cancer subscale.

Trial Locations

Locations (1)

AC Camargo Cancer Center

🇧🇷

Sao Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath